Ochre Bio
RNA medicines for liver diseases
Y CombinatorWinter 2020ActiveHealthcareTherapeuticsBiotechGenomics
What they do
Problem
Chronic liver diseases lack effective treatments that can address underlying disease mechanisms.
Solution
The company develops RNA-based medicines to treat chronic liver diseases.
Who it's for
Patients with chronic liver disease treated via healthcare providers and specialty clinics.
Founders
Quin Wills
Founder/CSO
Company timeline
- Founded2019
- YC batchWinter 2020
- StatusActive
- Team size50 people
- LocationOxford, England, United Kingdom
Similar startups
Quince Therapeutics
Quince TherapeuticsQuince Therapeutics (fka Cortexyme) is a late-stag…
Pardes Biosciences
We break viruses
Entelexo Biotherapeutics
Creating a New Class of Drugs to Address Incurable Autoimmune Diseases
Reverie Labs
Engineering next-generation, brain-penetrant cancer therapies.
Helix Nanotechnologies
Next-generation mRNA platform to solve cancer, COVID and climate.
Braveheart
Clinical-stage biotech developing precision therapy for hypertrophic…